After Officials Relaxed Laws 6 Canadian Terminal Cancer Patients Received Psilocybin
1.4 min readPublished On: April 8th, 2022By News Team
TORONTO – Under new guidelines governing access to psilocybin, the hallucinogenic component found in “magic” mushrooms, six terminally ill cancer patients in Canada got the country’s first legally produced psilocybin.
Over the weekend, the patients were given the medicine as well as counseling.
In January, Health Canada changed its rules to allow doctors to request access to manufactured psilocybin as part of a special access program for terminally sick patients.
Although psilocybin is prohibited in the United States, it has showed promise in the treatment of end-of-life anxiety in persons with terminal malignancies.
People could ask for exemptions to use psilocybin before, but there was no system in place for them to get access to professionally made medications.
That meant they had to either grow their own mushrooms or buy it from an unauthorized dispensary.
Patients who have been approved for a manufactured version of psilocybin under Health Canada’s special access program can now obtain it from a licensed dealer who has been approved by the authority.
While the treatment tries to alleviate symptoms, it is not a cancer treatment.
(Spencer Hawkswell left, in photo from GrowOp)
It was a “momentous occasion,” according to Spencer Hawkswell, CEO of TheraPsil, an organization that helps Canadians get access to psychedelic therapy.
“This is a huge victory for patients and clinicians who have been in the dark for the past two years with legal exemptions but no psilocybin supply,” he said.
Patients didn’t always know what was within the substances they were buying, according to Hawkswell, who spoke to the Vancouver Sun.
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
BOCA RATON, Fla. - Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF), a multi-state cannabis operator, announced it is expanding its retail footprint in California with the opening of its 32nd retail location nationally and third ...
NORWOOD, Mass. - MariMed Inc. (OTCQX: MRMD), a multi-state cannabis operator focused on improving lives every day, today announced the appointment of Jon Levine to the new role of Chief Administration Officer and the appointment ...
Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF), a U.S. multi-state cannabis operator, announced that the Massachusetts Cannabis Control Commission has granted a final license for the sale of adult-use cannabis at its AYR Back Bay ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more